Efficacy and safety of remdesivir and favipiravir in COVID-19 patients - A systematic review and meta-analysis. [PDF]
Vatsha P+5 more
europepmc +1 more source
REMDESIVIR CAUSING PROFOUND BRADYCARDIA
Saif Aldeen Al-Adwan+3 more
openaire +2 more sources
Eco-friendly spectrofluorimetric determination of remdesivir in the presence of its metabolite in human plasma for therapeutic monitoring in COVID-19 patients. [PDF]
El-Fattah MHA+3 more
europepmc +1 more source
Green synchronous spectrofluorimetric analysis of remdesivir, the first approved antiviral, with levodropropizine as add-on therapy for covid-19: application in their pharmaceutical dosage form, and spiked human plasma. [PDF]
El-Adl SM+3 more
europepmc +1 more source
Incidence of COVID-19 Symptom Rebound After Treatment with Remdesivir. [PDF]
Gupta K+6 more
europepmc +1 more source
A deep learning and molecular modeling approach to repurposing Cangrelor as a potential inhibitor of Nipah virus. [PDF]
John L+5 more
europepmc +1 more source
Intravenous Administration of Remdesivir at the Acute Phase of SARS-CoV-2 Infection Is Associated with a Lower Prevalence of Post-COVID-19 Pain. [PDF]
Fernández-de-Las-Peñas C+10 more
europepmc +1 more source
Population Pharmacokinetic Modelling of Remdesivir and Its Metabolite GS-441524 in Hospitalised Patients with COVID-19. [PDF]
Roberts DM+18 more
europepmc +1 more source
Ensitrelvir in Hospitalized Patients with SARS-CoV-2 During the Omicron Epidemic: A Single-Center Observational Study. [PDF]
Yamato M+5 more
europepmc +1 more source
Efficacy of oral remdesivir in treating feline infectious peritonitis: a prospective observational study of 29 cats. [PDF]
Renner KA+5 more
europepmc +1 more source